Pfizer Inc. (PFE) Stock Overview
Explore Pfizer Inc.’s financial performance, market position, analyst ratings, and future outlook.
Pfizer Inc. (PFE)
Key Financials
Key Financials
Market Cap
154.2B
P/E Ratio
35.74
EPS (TTM)
$3.05
ROE
0.05%
PFE Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Pfizer Inc. (NYSE: PFE) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Pfizer Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of PFE on the NYSE shows an RSI of 73.02, suggesting the stock is in a an overbought condition. Our forecasting models predict a 12-month price target of $28.15 for the NYSE listing.
Key metrics behind Pfizer Inc.'s NYSE-traded stock include a P/E ratio of 35.74 and a market capitalization of 154.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of PFE on the NYSE.